🇺🇸 FDA
Patent

US 7659283

Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases

granted A61PA61P1/04A61P1/18

Quick answer

US patent 7659283 (Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61P, A61P1/04, A61P1/18, A61P11/00, A61P11/02